Mohammed Kaif Imtiyaz Khan’s Post

I am thrilled to share that I have successfully completed the NIDA Clinical Trials Network - Good Clinical Practice (GCP) course, certified by the National Institute on Drug Abuse (NIDA). This six-hour training focused on critical aspects of clinical research, including participant safety, informed consent, adverse events, and quality assurance, among other essential modules. This certification not only strengthens my foundation in clinical research but also enhances my commitment to ensuring high standards of patient care and safety in the field of clinical trials. Looking forward to applying this knowledge in future research endeavors! #ClinicalResearch #GoodClinicalPractice #NIDA #Healthcare #PatientSafety

Excited to share with you all that,I've Successfully completed the Good Clinical Practices(GCP) Course Offered by The NIDA Clinical Trial Network! This course covered the crucial aspect Such as IRB,Informed Consent,Participant safety,Quality assurance,Confidentiality & Privacy and more. A big thanku to the NDTA CTN Clinical coordinating centre and the National institute on Drug abuse for this valuable opportunity. Excited to apply this knowledge in my upcoming projects and Career! #Clinical research #Good clinical practice #Proffesional development #Clinical Trials

One month ago, I completed 'The National Institute on Drug Abuse (NIDA)' certification course, deepening my understanding of Good Clinical Practice and its importance in ensuring ethical and scientific quality in clinical trials. Grateful for the knowledge gained and excited to apply it in advancing clinical research and patient safety. #NIDA #ClinicalResearch #ProfessionalDevelopment #Certification

Learning about good clinical Practice (GCP) from the training course of the national institute of Drug Abuse (NIDA), gave me a deeper understanding of how clinical research works and the enormous work of people behind it. I have completed my training on Good clinical practice by NIDA Clinical Trial Networks on 26 August 2024. #GCP #certificate #NIDA

I’m Happy to announce that I’ve successfully completed the Good Clinical Practice certification from NIDA Clinical Trials Network. This program has enhanced my understanding of crucial aspects such as informed consent, data confidentiality,participant protection, quality control, and ethical practices in clinical research. I’m eager to implement these principles to ensure excellence in clinical trials and research. #ClinicalResearch #GoodClinicalPractice #ICHGCP #NIDACTN #EthicalResearch #ClinicalTrials

✨ Excited to share a new milestone! 🎉 I have successfully obtained the Good Clinical Practice (GCP) Certificate through the National Institute on Drug Abuse (NIDA). This certification equips me with essential knowledge of ethical and regulatory standards in clinical research. It enhances my skills in IRB, research protocols, protecting participant safety, informed consent, serious adverse event, quality assurance, Investigational New Drug(IND) and contributing to meaningful advancements in health science. #ClinicalResearch #GCP #PublicHealth #EthicsInResearch #ProfessionalDevelopment

Eshmoun Clinical Research is exerting all efforts and resources to contribute to transform Africa from consumer region to producrer region in data health field.

In regulatory documents, terminology can often vary and lead to confusion, impacting effective communication and decision-making. To address this, the FDA and The National Institutes of Health (NIH) have collaborated through the FDA-NIH Clinical Research Working Group (CRWG) to develop a draft glossary of 37 essential terms related to innovative clinical trial design. This glossary serves as a critical resource to: ✅ Improve clarity and understanding ✅ Strengthen scientific communication ✅ Support informed clinical and regulatory decisions The attached resource is a valuable tool for regulatory professionals, helping create a more consistent and clear approach to clinical research. #MedicalWriter #RegulatoryAffairs #ClinicalResearch #FDA #NIH #Innovation #ClinicalTrials #HealthcareProfessionals

🌐 🔍 The Clinical Trials Regulation in the EU has taken a significant step forward. ✍ On January 31, 2022, the Clinical Trials Directive (EC) No. 2001/20/EC and national implementing legislation across EU Member States were repealed. 👍 This momentous change harmonizes the processes for assessment and supervision of clinical trials within the European Union (EU). 💡 Prior to the Regulation, clinical trial sponsors had to navigate a complex landscape. They had to submit separate applications to national competent authorities and ethics committees in each country for regulatory approval. 📌 This fragmented approach often led to delays and inefficiencies. The new Regulation introduces a transformative shift. Sponsors can now submit a single online application via the Clinical Trials Information System (CTIS). 🔑 This streamlined process facilitates multinational trials across several European countries, promoting efficiency and collaboration. 🌟 Key Benefits: 👀 Improved Information-Sharing: The CTIS enables seamless communication between stakeholders, enhancing transparency and cooperation. 👀 Enhanced Safety Standards: Participants in EU clinical trials benefit from standardized safety measures. 👀 Fostering Innovation: Joint evaluation and authorization by EU Member States encourage research breakthroughs. 🌍🔬👩⚕️Let’s embrace this positive change and continue advancing medical research together! ⚕ ❓ Should you require supplementary information or more comprehensive particulars, please do not hesitate to make an inquiry. ❓ #ClinicalTrials #MedicalResearch #EURegulation #Innovation #Regulatoryintelligence #CTA #clinicalpharmacy #CTIS #Regulatorycompliance

⭐ Regulatory Update ⭐ The rules on EMA publication of Clinical Trials Information via the public part of CTIS have been revised to simplify the information published and remove the option to defer publication for any type of clinical trial. Many of the other supporting documents have also been updated to cover these changes and can be found here: https://buff.ly/4cB1Lgd #clinicaltrials #clinicalresearch #clinical